Theravance Biopharma (TBPH) FY 2025 Conference May 20, 2025 10:30 AM ET Speaker0 Okay. I think we'll get started with our next presentation. Okay. I think we'll get Okay. I think we'll get started with our next presentation. So I'm Doug Sav, senior analyst at H. C. Wainwright. We are thrilled to have us with us, Theravance Biopharma, represented by the company's CEO, Rick Winningham. So, a lot to ground to cover. And so maybe we'll start with YUPELRI, which is your approved on market treatment for COPD. And ...